---
title: "Synexus Clinical Research Finance Limited — Ownership Dossier"
canonical: https://whiteintel.dev/entity/3b02aa2f-6192-4910-9686-0f095db5e249
json: https://whiteintel.dev/api/public/dossier/3b02aa2f-6192-4910-9686-0f095db5e249
identifier: gb-coh:06408428
jurisdiction: GB
risk: Low
source: WhiteIntel corporate-ownership graph
---

# Synexus Clinical Research Finance Limited

**Type:** Company  
**Jurisdiction:** [GB](https://whiteintel.dev/jurisdictions/gb)  
**Identifier:** `gb-coh:06408428`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/3b02aa2f-6192-4910-9686-0f095db5e249  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/3b02aa2f-6192-4910-9686-0f095db5e249  

## Ownership & control

### Holdings / subsidiaries

- **SYNEXUS CLINICAL RESEARCH ACQUISITIONS LIMITED** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/d0494c05-c123-5c41-b4a7-fe27396f3b30

## Company profile (live · UK Companies House)

- **Company number:** `06408428`
- **Status:** dissolved
- **Type:** ltd
- **Incorporated:** 2007-10-24
- **Registered office:** 12b Granta Park, Great Abington, Cambridge, CB21 6GB, England
- **SIC:** 74909

### Officers

- HARRIS, Richard Stuart — director · British · appointed 2021-12-29
- JAMES, Julia Mary — director · British · appointed 2016-05-31
- HARLAND, David William Romanis — secretary · British · appointed 2007-10-26 · resigned 2008-06-24
- MCCLUSKEY, Paul — secretary · British · appointed 2008-06-25 · resigned 2011-06-30
- TRAVERS SMITH SECRETARIES LIMITED — corporate secretary · appointed 2007-10-24 · resigned 2007-10-26
- BERTHOUX, Christophe — director · French · appointed 2010-09-13 · resigned 2016-05-31
- CHAMBERS, Paul Michael — director · British · appointed 2011-09-23 · resigned 2016-05-31
- FORT, Michael John — director · British · appointed 2008-06-24 · resigned 2011-04-08
- HAND, Jeremy, Mr. — director · British · appointed 2007-10-26 · resigned 2008-06-25
- HARLAND, David William Romanis — director · British · appointed 2007-10-26 · resigned 2008-06-25
- HARTMAN, Brainard Judd — director · American · appointed 2016-05-31 · resigned 2021-12-08
- MCCLUSKEY, Paul — director · British · appointed 2008-06-25 · resigned 2011-06-30
- NEILD, Christopher David — director · British · appointed 2016-05-31 · resigned 2020-03-13
- TRAVERS SMITH DIRECTORS LIMITED — corporate director · appointed 2007-10-24 · resigned 2007-10-26
- TRAVERS SMITH SECRETARIES LIMITED — corporate director · appointed 2007-10-24 · resigned 2007-10-26

### Beneficial owners (Persons with Significant Control)

- [Synexus Clinical Research Midco No 4 Limited](https://whiteintel.dev/entity/a1fc3264-2560-4ecd-9bec-6fb511782727) — 75–100% shares · corporate PSC · England — since 2016-04-06

## Get the full, resolved dossier (agent-callable)

The above is the free teaser. The resolved **multi-hop UBO chain**, ownership **%**, full **financial history**, itemised **assets** and the hop-by-hop **exposure path** are the paid depth — callable as tools from your agent:

```bash
npx -y @whiteintel/mcp-server   # then: get_dossier · trace_ownership_path · check_offshore_exposure
```

Or unlock a one-off cited dossier for **Synexus Clinical Research Finance Limited** — https://whiteintel.dev/entity/3b02aa2f-6192-4910-9686-0f095db5e249 · pricing https://whiteintel.dev/pricing.

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **Synexus Clinical Research Finance Limited**. Human view: https://whiteintel.dev/entity/3b02aa2f-6192-4910-9686-0f095db5e249 · Structured JSON: https://whiteintel.dev/api/public/dossier/3b02aa2f-6192-4910-9686-0f095db5e249._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._